Results 111 to 120 of about 561,925 (299)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Random Number Generation by Mode Hopping of VCSEL Using Optical Feedback

open access: yesGuangtongxin yanjiu, 2023
Recent research results show that great progress has been made in improving the generation rate of physical random numbers. However, there are still some defects such as complex generation process and large volume.
ZHANG Yu-ling   +5 more
doaj  

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Exploring number space by random digit generation [PDF]

open access: yes, 2007
There is some evidence that human subjects preferentially select small numbers when asked to sample numbers from large intervals "at random”. A retrospective analysis of single digit frequencies in 16 independent experiments with the Mental Dice Task ...
Brugger, Peter, Loetscher, Tobias
core   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Colloidal particles as noise source for random number generation

open access: yesAIP Advances
In this work, we investigate colloidal particle patterns as a possible noise source for random number generation. We systematically analyze the minimum entropy of the noise source over different particle concentrations of {1, 3, 5, 7, 10, 12, 15} mg/ml ...
Alexander Scholz   +2 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

LEFT DLPC TSMS: EFFECTS ON RANDOM NUMBER GENERATION

open access: yesIBRO Neuroscience Reports, 2023
Vanesa Soto-León   +3 more
doaj   +1 more source

Simultaneous biometric verification and random number generation

open access: yes, 2006
A new method of simultaneous biometric verification and generation of a random number for use in authenticated encrypted communication is described. A non-linear transform is applied to a vector derived from a biometric.
Chen, Brenden Chong, Chandran, Vinod
core  

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

open access: yesMolecular Oncology, EarlyView.
Many patients with urothelial cancer do not benefit from treatment with pembrolizumab, while at risk of severe side effects. Changes in the levels of circulating tumor DNA early during treatment, measured by a simple and affordable assay that can be easily implemented in the clinic, can be used as a prognostic tool to identify these patients.
Youssra Salhi   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy